Evidence map›Paper›PMID 41459190›Full record

ArticleMicroplastics and nanoplastics2025

Advancing pyrolysis-gas chromatography-mass spectrometry for the accurate quantification of micro- and nanoplastics in human blood.

Federica Nardella, Marthinus Brits, Martin J M van Velzen, Lorenzo Scibetta, Amanda Durkin, Roel Vermeulen, Frederic Béen, Sicco H Brandsma, Marja H Lamoree

Abstract read
In one paragraph

Article in Microplastics and nanoplastics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Federica Nardella *Amsterdam Institute for Life and Environment (A-LIFE), Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
Marthinus Brits *Amsterdam Institute for Life and Environment (A-LIFE), Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
Martin J M van VelzenAmsterdam Institute for Life and Environment (A-LIFE), Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
Lorenzo ScibettaAmsterdam Institute for Life and Environment (A-LIFE), Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
Amanda DurkinInstitute for Risk Assessment Sciences, Utrecht University, Utrecht, The Netherlands.
Roel VermeulenInstitute for Risk Assessment Sciences, Utrecht University, Utrecht, The Netherlands.
Frederic BéenAmsterdam Institute for Life and Environment (A-LIFE), Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
Sicco H BrandsmaAmsterdam Institute for Life and Environment (A-LIFE), Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
Marja H LamoreeAmsterdam Institute for Life and Environment (A-LIFE), Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Quantification of micro- and nanoplastics (MNPs) in human samples is essential for accurately assessing human exposure and understanding the potential health impacts of these pervasive pollutants. Blood plays a key role in revealing potential MNPs exposure and its health impacts. The detection of MNPs in human blood, however, is analytically challenging due to the complex composition of the sample and the limited availability of sensitive analytical methods. Pyrolysis-gas chromatography-mass spectrometry (Py-GC-MS) using Selected Ion Monitoring (SIM) has been widely used to quantify MNPs in human blood. In this work the analytical approach was improved by employing full scan data acquisition. The mass concentration of six polymers widely used in plastic materials - poly(methyl methacrylate) (PMMA), polypropylene (PP), polystyrene (PS), polyethylene (PE), polyvinyl chloride (PVC), and polyethylene terephthalate (PET) - was determined in 102 human whole blood samples. Rigorous QA/QC measures were established which are essential for ensuring the reliability and accuracy of the method. Limits of detection (LODs) ranged from 14 ng/mL (PP) to 245 ng/mL (PE). The recoveries of the quantitation compounds ranged from 52 to 102%. MNPs were detected in all the samples investigated with PVC as the most frequently detected polymer (99% of all samples). For 20% of samples, the concentration was above the limit of quantification (LOQ) with an average total concentration of 386 ng/mL. The analysis of MNPs in human blood is relevant for future research to understand the pathways of MNP absorption, accumulation, and potential health risks associated with exposure to plastic pollutants. The use of full scan data acquisition enabled simultaneous ion monitoring allowing for more careful selection of quantitation compounds and provides the potential for retrospective data analysis. Supplementary Information: The online version contains supplementary material available at 10.1186/s43591-025-00152-7.

Indexed as

Human biomonitoringHuman bloodMicro- and nanoplasticsPyrolysis-gas chromatography-mass spectrometry

Identifiers

PMID41459190
PMCPMC12738653

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.